Author:
Campos Maria Amélia A,Oppermann Maria Lúcia R,Sanseverino Maria Teresa V,Guerra Giulia L,Hirakata Vânia N,Reichelt Angela J
Abstract
Abstract
Objective
To describe the frequency and types of congenital anomalies and associated risk factors in Brazilian women with type 2 diabetes.
Methods
In this retrospective cohort study between 2005 and 2021, we included all pregnant participants with type 2 diabetes from the two major public hospitals in southern Brazil. We collected data from the electronic hospital records. Congenital anomalies were classified by the 10th revised International Classification of Diseases, Q chapter, enhanced by the EUROCAT registry classification, and categorized by type and gravity. We used multiple Poisson regression with robust estimates to estimate risks.
Results
Among 648 participants, we excluded 19, and 62 were lost to follow-up; therefore, we included 567 participants. Overt diabetes arose in 191 participants (33.7%, 95% CI 30.0% – 38.0%). Less than 20% of the participants supplemented folate. Congenital anomalies occurred in 78 neonates (13.8%, CI 11.0 − 16.9%), 73 babies (93.6%) presented major anomalies, and 20 (10.5%) cases occurred in participants with overt diabetes. Cardiac anomalies were the most frequent (43 isolated and 12 combined). Pre-eclampsia was associated with an increased risk in the analyses including all women (adjusted RR 1.87 (95% CI 1.23–2.85), p = 0.003), but not in analyses including only women with an HbA1c measured up to the 14th gestational age. HbA1c, either measured at any time in pregnancy (adjusted RR 1.21 (95% CI 1.10–1.33), p < 0.001) or up to the first 14 weeks (adjusted RR 1.22, 95% CI 1.10–1.35, p < 0.001) was the only sustained risk factor. Risk factors such as maternal age, obesity, diabetes diagnosis, or use of antidiabetic medications were not associated with congenital anomalies.
Conclusion
We found a high frequency of congenital anomalies associated with poor maternal glycemic control and revealed an almost universal lack of preconception care. An urgent call to action is mandatory for the reversal of this gray scenario.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. International Diabetes Federation. IDF Diabetes Atlas. 2021 [acessed February 13, 2024]; 10th edn: [ https://www.diabetesatlas.org].
2. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Departamento de Análise em Saúde e Vigilância de Doenças Não Transmissíveis. Vigitel Brasil 2023: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico: estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2023 [recurso eletrônico]. Brasília, Brasil: Ministério da Saúde, Secretaria de Vigilância em Saúde e Ambiente, Departamento de Análise Epidemiológica e Vigilância de Doenças Não Transmissíveis. 2023. Report No.: 978-65-5993-476-8.
3. Oppermann ML, Campos MA, Hirakata VN, Reichelt AJ. Overt diabetes imposes a comparable burden on outcomes as pregestational diabetes: a cohort study. Diabetol Metab Syndr. 2022;14(1):177. https://doi.org/10.1186/s13098-022-00939-1.
4. Balsells M, García-Patterson A, Gich I, Corcoy R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2009;94(11):4284–91. https://doi.org/10.1210/jc.2009-1231.
5. World Health Organization. Congenital disorders. 2024 [acessed January 20, 2024]; https://www.who.int/health-topics/congenital-anomalies#tab=tab_2.